Want to see HRGN full AI Analyst Report?
Harvard Apparatus Regenerative Technology (HRGN) Financial Statements
Harvard Apparatus Regenerative Technology Financial Overview
Harvard Apparatus Regenerative Technology's market cap is currently $46.65M. The company's EPS TTM is $-0.40; its P/E ratio is -5.79; Harvard Apparatus Regenerative Technology has not announced its next earnings date. See an overview of income statement, balance sheet, and cash flow financials.
| Dec 25 | Dec 24 | Mar 24 | Dec 22 | Mar 22 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 704.00K | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 |
| Gross Profit | $ 58.00K | $ -270.00K | $ -24.00K | $ 0.00 | $ 0.00 |
| Operating Income | $ -7.62M | $ -8.16M | $ -9.09M | $ -6.15M | $ -8.64M |
| EBITDA | $ -6.76M | $ -8.16M | $ -9.09M | $ -5.92M | $ -8.53M |
| Net Income | $ -6.87M | $ -7.73M | $ -9.02M | $ -6.07M | $ -7.98M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 1.35M | $ 2.49M | $ 432.00K | $ 1.24M | $ 1.24M |
| Total Assets | $ 2.68M | $ 4.44M | $ 2.61M | $ 2.40M | $ 1.87M |
| Total Debt | $ 199.00K | $ 294.00K | $ 48.00K | $ 147.00K | $ 169.00K |
| Net Debt | $ -1.15M | $ -2.19M | $ -384.00K | $ -1.09M | $ -1.07M |
| Total Liabilities | $ 1.62M | $ 1.22M | $ 968.00K | $ 1.41M | $ 4.89M |
| Stockholders' Equity | $ 1.06M | $ 3.22M | $ 1.65M | $ 989.00K | $ -3.03M |
| Cash Flow | |||||
| Free Cash Flow | $ -3.83M | $ -4.85M | $ -6.95M | $ -5.11M | $ -2.63M |
| Operating Cash Flow | $ -3.83M | $ -4.85M | $ -6.94M | $ -5.11M | $ -2.63M |
| Investing Cash Flow | $ 0.00 | $ 0.00 | $ -11.00K | $ -5.00K | $ 0.00 |
| Financing Cash Flow | $ 2.70M | $ 6.91M | $ 6.14M | $ 5.06M | $ 2.84M |
Currency in USD